Intrinsiqs

Is Claritev Corporation overvalued?

Claritev Corporation (CTEV) — key valuation metrics and fundamentals.

No verdict
Price
$38.12
Fair value
—
Current P/E
—
Normal P/E
22.1
Market cap
$649.9M
Dividend yield
0.0%
Return on equity
139.6%
Sector
Healthcare

See the full interactive analysis →

Fair value compares CTEV's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.RHHBY Roche Holding AGUNH UnitedHealth Group IncorporatedMRK Merck & Co., Inc.